{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:35:00Z","timestamp":1794108900062,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["PRDPM234206GALV"],"award-info":[{"award-number":["PRDPM234206GALV"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espana Ministerio de Ciencia e Innovacion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neuroscience.2026.08.021","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T14:55:21Z","timestamp":1786805721000},"page":"245-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Exploring the antidepressant-like effects of cannabidiol and\/or temozolomide in female mice with induced glioblastoma"],"prefix":"10.1016","volume":"614","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3159-4783","authenticated-orcid":false,"given":"Laura","family":"G\u00e1lvez-Melero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edurne","family":"Mugica-Urruzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4365-0412","authenticated-orcid":false,"given":"Elena","family":"Tovar-Ambel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1994-2386","authenticated-orcid":false,"given":"Guillermo","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Julia","family":"Garc\u00eda-Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.neuroscience.2026.08.021_b0005","doi-asserted-by":"crossref","DOI":"10.1002\/pon.70296","article-title":"Understanding the trajectory of depressive symptoms in newly diagnosed high\u2010grade glioma patients\u2014a meta\u2010analysis","volume":"34","author":"Abazari","year":"2025","journal-title":"Psychooncology"},{"issue":"13","key":"10.1016\/j.neuroscience.2026.08.021_b0010","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1038\/s41386-019-0524-3","article-title":"Analysis of sex differences in pre-clinical and clinical data sets","volume":"44","author":"Beltz","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.08.021_b0015","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00213-020-05481-4","article-title":"Decreased sensitivity in adolescent versus adult rats to the antidepressant-like effects of cannabidiol","volume":"237","author":"Bis-Humbert","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2026.08.021_b0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF \u2013 a key transducer of antidepressant effects","volume":"102","author":"Bj\u00f6rkholm","year":"2016","journal-title":"Neuropharmacology"},{"issue":"23","key":"10.1016\/j.neuroscience.2026.08.021_b0025","doi-asserted-by":"crossref","first-page":"12738","DOI":"10.3390\/ijms252312738","article-title":"Current and potential use of biologically active compounds derived from Cannabis sativa L. in the treatment of selected diseases","volume":"25","author":"Bukowska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.neuroscience.2026.08.021_b0030","doi-asserted-by":"crossref","first-page":"13376","DOI":"10.3390\/ijms241713376","article-title":"Melatonin prevents depression but not anxiety-like behavior produced by the chemotherapeutic agent temozolomide: implication of doublecortin cells and hilar oligodendrocytes","volume":"24","author":"Cabrera-Mu\u00f1oz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.08.021_b0035","first-page":"e3638","article-title":"The mouse forced swim test","volume":"59","author":"Can","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuroscience.2026.08.021_b0040","first-page":"e3769","article-title":"The tail suspension test","volume":"59","author":"Can","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.08.021_b0045","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3390\/cells10071783","article-title":"Sex-specific differences in glioblastoma","volume":"10","author":"Carrano","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.08.021_b0050","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2021.01.034","article-title":"Antidepressant drugs act by directly binding to TRKB neurotrophin receptors","volume":"184","author":"Casarotto","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2026.08.021_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctarc.2025.100888","article-title":"A systematic review of immunotherapies in combination with temozolomide as treatment for glioblastoma","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Treatment Res. Commun."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.08.021_b0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1667\/RR15540.1","article-title":"Neurological impairments in mice subjected to irradiation and chemotherapy","volume":"193","author":"Dey","year":"2020","journal-title":"Radiat. Res."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.08.021_b0065","first-page":"4555","article-title":"Personalised support of brain tumour patients during radiotherapy based on psychological profile and quality of life","volume":"29","author":"Dinapoli","year":"2021","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.08.021_b0070","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0006-3223(99)00177-8","article-title":"Neural plasticity to stress and antidepressant treatment","volume":"46","author":"Duman","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.08.021_b0075","doi-asserted-by":"crossref","first-page":"e1101","DOI":"10.1038\/tp.2017.68","article-title":"Depletion of adult neurogenesis using the chemotherapy drug temozolomide in mice induces behavioural and biological changes relevant to depression","volume":"7","author":"Egeland","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuroscience.2026.08.021_b0085","doi-asserted-by":"crossref","unstructured":"G\u00e1lvez-Melero, L., Garc\u00eda-Fuster, M.J., 2026. Unexpected antidepressant-like effects of temozolomide in a mixed sex-cohort of adult rats: role of hippocampal FADD protein. bioRxiv. https:\/\/doi.org\/10.64898\/2026.04.23.720315.","DOI":"10.64898\/2026.04.23.720315"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.08.021_b0080","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s43440-025-00750-5","article-title":"Adolescent cannabidiol treatment produces antidepressant-like effects without compromising long-term cognition in rats","volume":"77","author":"G\u00e1lvez-Melero","year":"2025","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuroscience.2026.08.021_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1873308","article-title":"Antidepressant-like effects of cannabidiol when combined with temozolomide in adult rats","volume":"17","author":"G\u00e1lvez-Melero","year":"2026","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.08.021_b0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1152\/jn.00581.2018","article-title":"Fluoxetine reverses brain radiation and temozolomide-induced anxiety and spatial learning and memory defect in mice","volume":"121","author":"Gan","year":"2019","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuroscience.2026.08.021_b0100","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.euroneuro.2020.10.008","article-title":"Sex differences in the antidepressant-like potential of repeated electroconvulsive seizures in adolescent and adult rats: regulation of the early stages of hippocampal neurogenesis","volume":"41","author":"Garc\u00eda-Cabrerizo","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"15\u201316","key":"10.1016\/j.neuroscience.2026.08.021_b0110","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1007\/s00213-016-4342-6","article-title":"Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD\/FADD ratio after chronic desipramine and fluoxetine administration","volume":"233","author":"Garc\u00eda-Fuster","year":"2016","journal-title":"Psychopharmacology"},{"issue":"277","key":"10.1016\/j.neuroscience.2026.08.021_b0105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuroscience.2014.07.027","article-title":"FADD adaptor and PEA-15\/ERK1\/2 partners in major depression and schizophrenia postmortem brains: basal contents and effects of psychotropic treatments","volume":"26","author":"Garc\u00eda-Fuster","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2026.08.021_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106953","article-title":"Cognitive awareness after treatment for high-grade glioma","volume":"210","author":"Giovagnoli","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.08.021_b0120","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/pharmaceutics17121537","article-title":"From screening to a nanotechnological platform: cannabidiol-chemotherapy co-loaded lipid nanocapsules for glioblastoma multiforme treatment","volume":"17","author":"G\u00f3mez-L\u00e1zaro","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuroscience.2026.08.021_b0125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1476-4598-9-270","article-title":"FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors","volume":"9","author":"Ho","year":"2010","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.08.021_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70160","article-title":"Recent advances in the therapeutic potential of cannabinoids against gliomas: a systematic review (2022-2025)","volume":"13","author":"Javid","year":"2025","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.neuroscience.2026.08.021_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1340386","article-title":"Sex-specific molecular differences in glioblastoma: assessing the clinical significance of genetic variants","volume":"13","author":"Jovanovich","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.08.021_b0140","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41398-022-01994-y","article-title":"Exploring pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective","volume":"12","author":"Ledesma-Corvi","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.08.021_b0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s10020-022-00560-y","article-title":"FADD as a key molecular player in cancer progression","volume":"28","author":"Liu","year":"2022","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuroscience.2026.08.021_b0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bcp.2018.08.023","article-title":"Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma","volume":"157","author":"L\u00f3pez-Valero","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.08.021_b0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bcp.2018.09.007","article-title":"Targeting glioma initiating cells with a combined therapy of cannabinoids and temozolomide","volume":"157","author":"L\u00f3pez-Valero","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.08.021_b0165","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/cdd.2010.170","article-title":"Stimulation of the midkine\/ALK axis renders glioma cells resistant to cannabinoid antitumoral action","volume":"18","author":"Lorente","year":"2011","journal-title":"Cell Death Differ."},{"issue":"8","key":"10.1016\/j.neuroscience.2026.08.021_b0160","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.08.021_b0170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5498\/wjp.v5.i3.273","article-title":"Psychiatric aspects of brain tumors: a review","volume":"5","author":"Madhusoodanan","year":"2015","journal-title":"World J Psychiatry."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.08.021_b0175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/00207454.2018.1527328","article-title":"Direct and indirect evidences of BDNF and NGF as key modulators in depression: role of antidepressants treatment","volume":"129","author":"Mondal","year":"2019","journal-title":"Int. J. Neurosci."},{"issue":"305","key":"10.1016\/j.neuroscience.2026.08.021_b0180","article-title":"Combination therapy with interferon-gamma as a potential therapeutic medicine in rat\u2019s glioblastoma: a multi-mechanism evaluation","volume":"15","author":"Moslemizadeh","year":"2022","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.08.021_b0185","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10143-018-1017-2","article-title":"Depression and glioblastoma, complicated concomitant diseases: a systemic review of published literature","volume":"43","author":"Mugge","year":"2020","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.neuroscience.2026.08.021_b0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cobeha.2019.01.009","article-title":"The interplay among psychological distress, the immune system, and brain tumor patient outcomes","volume":"28","author":"Otto-Meyer","year":"2019","journal-title":"Curr. Opin. Behav. Sci."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.08.021_b0205","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1007\/s12035-016-9922-2","article-title":"Neurogenesis inhibition prevents enriched environment to prolong and strengthen social recognition memory, but not to increase BDNF expression","volume":"54","author":"Pereira-Caixeta","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2026.08.021_b0200","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.nlm.2018.06.014","article-title":"Inhibiting constitutive neurogenesis compromises long-term social recognition memory","volume":"155","author":"Pereira-Caixeta","year":"2018","journal-title":"Neurobiol. Learn. Mem."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.08.021_b0210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2217\/cns.14.60","article-title":"Depression screening in patients with brain tumors: a review","volume":"4","author":"Pranckeviciene","year":"2015","journal-title":"CNS Oncology."},{"key":"10.1016\/j.neuroscience.2026.08.021_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.137723","article-title":"Cannabidiol exhibits anxiolytic-like effects and antipsychotic-like effects in mice models","volume":"826","author":"Shu","year":"2024","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.08.021_b0220","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/ph14121269","article-title":"Strain-, sex-, and time-dependent antidepressant-like effects of cannabidiol","volume":"14","author":"Silote","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.neuroscience.2026.08.021_b0225","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1457017","article-title":"Influence of neuropathological diagnosis on psychooncological distress in neurooncological patients - a retrospective cross-sectional analysis","volume":"14","author":"Staub-Bartelt","year":"2024","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.08.021_b0230","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.08.021_b0235","article-title":"Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance","volume":"1876","author":"Tomar","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.08.021_b0240","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1535-7163.MCT-10-0688","article-title":"A combined preclinical therapy of cannabinoids and temozolomide against glioma","volume":"10","author":"Torres","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.neuroscience.2026.08.021_b0245","article-title":"The forced swim test as a model of depressive-like behavior","volume":"97","author":"Yankelevitch-Yahav","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.08.021_fur1","article-title":"Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226005567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226005567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:29:05Z","timestamp":1789129745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226005567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"alternative-id":["S0306452226005567"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.08.021","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the antidepressant-like effects of cannabidiol and\/or temozolomide in female mice with induced glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization (IBRO).","name":"copyright","label":"Copyright"}]}}